Polskie Radio frames weight loss drugs such as Ozempic as the cause of an emerging health problem. Only the headline is available, so tap through for its argument.
Recap by typeshit. Full story at www.polskieradio.pl.
Peptide talk is everywhere from YouTube to Reddit. CNBC looks at what is actually known about their safety.
The post warns that people in their 50s and 60s may blame vision changes on age or screens, when researchers have tied the drug in Ozempic to a rare cause of sudden sight loss.
Facial fat loss during GLP-1 weight loss can mean hollowing, flatter cheeks and looser skin, and Dr. Makkani says creams won't solve all of it.
Health authorities are warning people off unregulated peptides as emergency departments report a rise in severe allergic reactions.
L'Oréal's CEO told investors GLP-1s are shifting skincare buying, while Carlsberg and Diageo play down any hit to beer demand.
The Korean drugmaker says it will show two sets of findings on its oral semaglutide for obesity and diabetes at the AAPS annual meeting.
Loading…